Zobrazeno 1 - 10
of 9 577
pro vyhledávání: '"antiphospholipid antibodies"'
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-14 (2024)
Abstract Background Systemic Lupus Erythematosus (SLE) is a multifaceted autoimmune disorder characterized by diverse clinical manifestations, including a significant prevalence of headaches. This cross-sectional study aimed to thoroughly explore the
Externí odkaz:
https://doaj.org/article/7a6a4d09ffaf492ea5fe717b0fb69713
Autor:
Brian P. Edwards, Sidhartha Gautam Senapati, Mariia Kasianchyk, Joel Shah, Fatih Ayvali, Satish Maharaj
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 1053-1056 (2024)
Abstract Autoimmune hemolytic anemia (AIHA) is an acquired condition caused by autoantibody mediated destruction of erythrocytes. AIHA is classified as warm or cold depending on whether the autoantibodies involved react optimally at or below body tem
Externí odkaz:
https://doaj.org/article/92b8e86ef5ba4d3d94566740828fa77f
Autor:
D. R. Eremeeva, M. S. Zainulina
Publikováno v:
Акушерство, гинекология и репродукция, Vol 18, Iss 4, Pp 475-491 (2024)
Introduction. The role of antiphospholipid antibody (APA) carriage in the pathogenesis of pregnancy failure is one of the most recently debated issues. To date, no unified therapeutic approach to immunotherapy of antiphospholipid syndrome (APS) in pr
Externí odkaz:
https://doaj.org/article/586bd8c488e843669672cf8950074c3c
Publikováno v:
Radiology Case Reports, Vol 19, Iss 12, Pp 6047-6052 (2024)
Antiphospholipid syndrome (APS) is characterized by hypercoagulability, manifesting as venous or arterial thrombosis, and pregnancy-related complications, such as fetal loss, pre-eclampsia, and eclampsia. These conditions occur in the presence of ant
Externí odkaz:
https://doaj.org/article/fd539a05f0a945a9ac003fc9c345a356
Publikováno v:
Klinicist, Vol 18, Iss 1, Pp 78-87 (2024)
Antiphospholipid syndrome (APS) is a systemic autoimmune pathology characterized by thrombotic manifestation associated with antiphospholipid antibodies (aPL) and phospholipid-binding proteins circulation. Long-term anticoagulant therapy is a corners
Externí odkaz:
https://doaj.org/article/f4e2cffe008c42558144473cabe0ec9b
Autor:
T. M. Reshetnyak, F. A. Cheldieva, N. M. Kosheleva, A. A. Shumilova, L. M. Blank, N. V. Seredavkina
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 325-330 (2024)
Obstetric pathology (pregnancy loss at different gestational ages; premature delivery of morphologically normal foetus due to pre-/eclampsia or placental insufficiency), along with thrombotic complications are the main clinical manifestations of anti
Externí odkaz:
https://doaj.org/article/fb3c934fe22043f8bd437d4f4bf1222d
Publikováno v:
PeerJ, Vol 12, p e18419 (2024)
Objective The purpose of the present study was to evaluate whether intravenous immunoglobulin (IVIG) increases live birth rates and improves neonatal results in patients with antiphospholipid antibodies (aPL) at high-risk for miscarriage. Background
Externí odkaz:
https://doaj.org/article/6612e157cf3346b5b12c8775ef715e23
Autor:
Jie Gao, Yan Zheng, Zhuo Wang, Junfeng Jia, Jian Wan, Qing Han, Xi Zheng, Renli Liu, Zhaohui Zheng, Kaichun Wu, Ping Zhu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesThe aim of this study is to assess the risk factors associated with thrombotic events in obstetric antiphospholipid syndrome (OAPS) patients and to develop a predictive model specifically tailored to predict the risk of postpartum thrombosi
Externí odkaz:
https://doaj.org/article/2f7824ed48db4303a531628ed87a8d45
Autor:
Yinan Wang, Pinni Yang, Zhengbao Zhu, Hao Peng, Xiaoqing Bu, Qingyun Xu, Aili Wang, Jing Chen, Tan Xu, Yonghong Zhang, Jiang He
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 19 (2024)
Background Antiphospholipid antibodies (aPLs) have been reported to be involved in platelet‐mediated thrombosis and inflammation, but the impact on the prognosis of ischemic stroke remains unclear. We aimed to examine whether the association betwee
Externí odkaz:
https://doaj.org/article/e70b2de66cab4c82bb50f045b37e5788
Autor:
Tatiana M. Reshetnyak, Fariza A. Cheldieva, Svetlana I. Glukhova, Kamila S. Nurbaeva, Nataliya V. Seredavkina, Mariya V. Cherkasova, Alexander M. Lila, Evgeny L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 4 (2024)
Thrombotic antiphospholipid syndrome (APS) is a condition affecting young people in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL).The aim of this study was the evaluation of the incidence of recur
Externí odkaz:
https://doaj.org/article/1428993700ed44f597b48a871e1f56c7